Radiosensitization of solid tumor cell lines by an MDM2 inhibitor

被引：0
|
作者：
Cerna, David [1 ]
Li, Hongyun [1 ]
Flaherty, Siobhan [1 ]
Carter, Donna [1 ]
Coleman, C. Norman [2 ]
Yoo, Stephen [2 ]
机构：
[1] SAIC Frederick, Frederick, MD USA
[2] NCI, Rockville, MD USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-2668
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2668
引用
收藏
页数：1
相关论文
共 50 条
  • [31] On the biosynthesis of an inhibitor of the p53/MDM2 interaction
    Duncan, SJ
    Williams, DH
    Ainsworth, M
    Martin, S
    Ford, R
    Wrigley, SK
    TETRAHEDRON LETTERS, 2002, 43 (06) : 1075 - 1078
  • [32] Discovery of CGM097 as a novel Mdm2 inhibitor
    Masuya, Keiichi
    Furet, Pascal
    Stutz, Stefan
    Holzer, Philipp
    Pissot-Soldmann, Carole
    Buschmann, Nicole
    Valat, Therese
    Ferretti, Stephane
    Ruetz, Stephan
    Rynn, Caroline
    Berghausen, Joerg
    Jacoby, Edgar
    Lang, Marc
    Gabriel, Tobias
    Hofmann, Francesco
    Kallen, Joerg
    Jeay, Sebastien
    Gessier, Francois
    CANCER RESEARCH, 2014, 74 (19)
  • [33] MDM2 promotes tumor cell migration through the induction of epithelial to mesenchymal transition
    Zheng, Lin
    Wu, Yeping
    Zhou, Tianyi
    Zhu, Hong
    He, Qiaojun
    Yang, Bo
    CANCER RESEARCH, 2015, 75
  • [34] BCL2/MDM2 Inhibitor Combo Effective in AML
    Caruso, Catherine
    CANCER DISCOVERY, 2019, 9 (02) : 156 - 156
  • [35] Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study
    Takahashi, Shunji
    Fujiwara, Yutaka
    Nakano, Kenji
    Shimizu, Toshio
    Tomomatsu, Junichi
    Koyama, Takafumi
    Ogura, Mariko
    Tachibana, Masaya
    Kakurai, Yasuyuki
    Yamashita, Tomonari
    Sakajiri, Sakura
    Yamamoto, Noboru
    CANCER SCIENCE, 2021, 112 (06) : 2361 - 2370
  • [36] The expression of MDM2, MDM4, p53 and p21 in myeloid neoplasms and the effect of MDM2/MDM4 dual inhibitor
    Eskandari, Mohammad
    Shi, Yang
    Liu, John
    Albanese, Joseph
    Goel, Swati
    Verma, Amit
    Wang, Yanhua
    LEUKEMIA & LYMPHOMA, 2021, 62 (01) : 167 - 175
  • [37] MDM2, an introduction
    Iwakuma, T
    Lozano, G
    MOLECULAR CANCER RESEARCH, 2003, 1 (14) : 993 - 1000
  • [38] MDM2 and prognosis
    Onel, K
    Cordon-Cardo, C
    MOLECULAR CANCER RESEARCH, 2004, 2 (01) : 1 - 8
  • [39] EVALUATION OF THE PARP INHIBITOR OLAPARIB IN PEDIATRIC SOLID TUMOR CELL LINES
    Norris, Robin
    Adamson, Peter
    Fox, Elizabeth
    PEDIATRIC BLOOD & CANCER, 2011, 56 (06) : 957 - 957
  • [40] Comparison of the antitumor effects of an MDM2 inhibitor, nutlin-3, in feline lymphoma cell lines with or without p53 mutation
    Mochizuki, Hiroyuki
    Goto-Koshino, Yuko
    Sato, Masahiko
    Fujino, Yasuhito
    Ohno, Koichi
    Tsujimoto, Hajime
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2012, 147 (3-4) : 187 - 194
12345